These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31153370)

  • 1. Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia.
    Wang X; Cai G; Wang Y; Liu R; Xi Z; Li G; Wen W; Wu Y; Wang C; Ji Q; Wang X; Zhang Q; Zeng Y; Wang L; Liu W; Zhou Y
    Lipids Health Dis; 2019 Jun; 18(1):131. PubMed ID: 31153370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.
    Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and clinical characteristics of familial hypercholesterolemia among Chinese patients undergoing coronary angiography due to angina-like chest pain].
    Zhang HW; Li S; Guo YL; Zhu CG; Wu NQ; Liu G; Dong Q; Sun J; Li JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):104-108. PubMed ID: 29495232
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.
    Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
    Nawaka N; Rattanawan C; Pussadhamma B; Wutthimanop A; Nuinoon M; Porntadavity S; Theansun W; Jeenduang N
    Postgrad Med; 2023 May; 135(4):410-417. PubMed ID: 36803651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
    J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes.
    Sun D; Cao YX; You XD; Zhou BY; Li S; Guo YL; Zhang Y; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Endocrinol Invest; 2019 May; 42(5):591-598. PubMed ID: 30276670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
    PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.